Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group.
暂无分享,去创建一个
F. Jardin | B. Coiffier | H. Tilly | C. Haioun | J. Emile | M. Macro | F. Peyrade | J. Gabarre | C. Fruchart | R. Delarue | O. Fitoussi | B. Corront | B. Choufi | H. Ghesquières | H. Farhat | V. Delwail | S. Bologna | L. Pascal | C. Fermé | J. Schiano